结果发现，在24名治疗前KRAS为野生型的患者中有9名(38%)患者的血清检测出突变型KRAS。其中3名的突变为多位点的不同突变。

We found that 9 out of 24 (38%) patients whose tumours were initially KRAS wild type developed detectable mutations in KRAS in their sera, three of which developed multiple different KRAS mutations.

youdao

结果发现，在24名治疗前KRAS为野生型的患者中有9名(38%)患者的血清检测出突变型KRAS。其中3名的突变为多位点的不同突变。

We found that 9 out of 24 (38%) patients whose tumours were initially KRAS wild type developed detectable mutations in KRAS in their sera, three of which developed multiple different KRAS mutations.

youdao